These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 1716899
21. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, Haïm T, Kahn MF, Chatellier G. Br J Rheumatol; 1996 Jul; 35(7):620-4. PubMed ID: 8670593 [Abstract] [Full Text] [Related]
26. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. Simon M, Girbal E, Sebbag M, Gomès-Daudrix V, Vincent C, Salama G, Serre G. J Clin Invest; 1993 Sep; 92(3):1387-93. PubMed ID: 7690781 [Abstract] [Full Text] [Related]
28. Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Meyer O, Combe B, Elias A, Benali K, Clot J, Sany J, Eliaou JF. Ann Rheum Dis; 1997 Nov; 56(11):682-5. PubMed ID: 9462172 [Abstract] [Full Text] [Related]
30. Antifilaggrin autoantibodies in early rheumatoid arthritis. Forslind K, Vincent C, Serre G, Svensson B. Scand J Rheumatol; 2000 Nov; 29(5):320-2. PubMed ID: 11093599 [Abstract] [Full Text] [Related]
31. Rheumatoid factors, anti-filaggrin antibodies and low in vitro interleukin-2 and interferon-gamma production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis. A preliminary study. Vittecoq O, Jouen-Beades F, Krzanowska K, Bichon-Tauvel I, Ménard JF, Daragon A, Tron F, Le Loët X. Joint Bone Spine; 2001 Mar; 68(2):144-53. PubMed ID: 11324930 [Abstract] [Full Text] [Related]
33. Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies. Meyer O, Tauxe F, Fabregas D, Gabay C, Goycochea M, Haim T, Elias A, Kahn MF. Clin Exp Rheumatol; 1993 Mar; 11(5):473-8. PubMed ID: 7506130 [Abstract] [Full Text] [Related]
34. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M. Ann Rheum Dis; 1992 Jun; 51(6):743-6. PubMed ID: 1377463 [Abstract] [Full Text] [Related]
35. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, Heikkilä R, Nykänen M, von Essen R. Int Arch Allergy Immunol; 1998 Apr; 115(4):294-302. PubMed ID: 9566352 [Abstract] [Full Text] [Related]
38. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournié B, Cantagrel A, Jolivet M, Serre G. Ann Rheum Dis; 2001 Sep; 60(9):882-7. PubMed ID: 11502616 [Abstract] [Full Text] [Related]
39. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection. Cojocaru M, Cojocaru IM, Iacob SA. Rom J Intern Med; 2004 Sep; 42(4):709-14. PubMed ID: 16366142 [Abstract] [Full Text] [Related]
40. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Vencovský J, Machácek S, Sedová L, Kafková J, Gatterová J, Pesáková V, Růzicková S. Ann Rheum Dis; 2003 May; 62(5):427-30. PubMed ID: 12695154 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]